Welcome to our dedicated page for Cencora SEC filings (Ticker: COR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cencora, Inc. filings document material events for a NYSE-listed pharmaceutical distribution and healthcare solutions company. Recent 8-K disclosures furnish quarterly operating results, Regulation FD information, executive officer transition details, annual meeting voting results and entries into material definitive agreements.
The company’s regulatory record also covers capital-structure matters, including common stock and listed senior notes, registered public debt offerings and the terms of multiple senior note maturities. Governance filings describe director elections and other shareholder voting matters, while material-event reports connect financing activity and completed acquisitions to the company’s operating and financial disclosures.
Cencora, Inc. executive Pawan Verma reported routine equity transactions on Form 4. On 11/20/2025, 1,974 restricted stock units were converted into shares of common stock, reflecting the vesting of a prior equity grant received for no consideration.
On the same date, 1,010 shares were withheld at a price of $362.07 to cover tax obligations tied to the vesting. After these transactions, Verma directly beneficially owned 5,148.05 shares of Cencora common stock and 3,948 restricted stock units remained outstanding.
Cencora, Inc. (COR) Executive Vice President Silvana Battaglia reported equity award activity in a Form 4. On 11/20/2025, 932 restricted stock units vested and were settled into an equal number of common shares. To satisfy tax withholding obligations tied to this vesting, 406 common shares were automatically disposed of at $362.07 per share. Following these transactions, she directly beneficially owned 20,473.464 Cencora common shares and held 1,865 remaining restricted stock units.
Cencora, Inc. (COR) President & CEO and director Robert P. Mauch reported routine equity transactions. On 11/18/2025, he exercised a non-qualified stock option to acquire 3,763 shares of common stock at an exercise price of $86.09 per share. On the same date, he sold 5,096 shares of common stock at a price of $366.64 per share under a pre-arranged Rule 10b5-1 trading plan adopted on 11/15/2024.
After these transactions, Mauch directly beneficially owned 65,746 shares of Cencora common stock and held 11,288 derivative securities in the form of stock options. The option exercised on 11/18/2025 related to a grant that became exercisable in four equal installments on 11/13/2020, 11/13/2021, 11/13/2022 and 11/13/2023.
COR reports that an affiliate intends to sell 5,096 shares of its common stock on the NYSE through Fidelity Brokerage Services LLC. The planned sale has an aggregate market value of 1,868,397.44, compared with 193,877,881 common shares outstanding.
The shares to be sold come from 1,333 shares acquired on 11/08/2024 via restricted stock vesting as compensation and 3,763 shares acquired on 11/18/2025 from an option granted on 11/13/2019 and paid for in cash. The seller, identified as Robert P. Mauch, has sold additional common shares during the past three months: 4,968 shares on 08/18/2025 for gross proceeds of 1,458,257.04; 5,097 shares on 09/18/2025 for 1,478,130.00; and 5,097 shares on 10/20/2025 for 1,665,699.60.
COR reported a planned stock sale under Rule 144 by shareholder Steven Collis. The notice covers the proposed sale of 31,349 common shares through Fidelity Brokerage Services on the NYSE, with an indicated aggregate market value of 11,493,797.36. The filing states that there were 193,877,881 common shares outstanding when the notice was prepared.
The shares to be sold come from 2,000 shares acquired via restricted stock vesting on 09/30/2023 and 29,349 shares acquired on 11/18/2025 through an option originally granted on 11/13/2019 and paid for in cash. Over the past three months, the same shareholder has sold additional common shares in several transactions, including 14,579 shares on 08/19/2025, 31,350 shares on 09/16/2025, 31,350 shares on 10/21/2025, and 50,000 shares on 11/06/2025, with gross proceeds disclosed for each sale.
Cencora (COR) reported insider equity activity by President & CEO and Director Robert P. Mauch. On 11/13/2025, he acquired 42,944 common shares at $0 upon satisfaction of performance share unit criteria, then had 18,677 shares withheld at $312.53 to cover taxes, resulting in 67,079 shares directly owned after these transactions. Separately, on 11/12/2025, he received a grant of 15,960 RSUs that vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.
Cencora (COR) reported insider activity by CFO James F. Cleary. On 11/13/2025, he acquired 30,062 shares of common stock at $0 upon satisfaction of performance share unit criteria, and 13,901 shares were withheld at $312.53 to satisfy tax obligations tied to that vesting. Following these transactions, he directly held 133,889.3479 shares.
Separately, on 11/12/2025, Cleary was granted 4,733 restricted stock units for no consideration. These RSUs vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.
Cencora (COR) reported an insider equity award. EVP, Chief Data & Info Officer Pawan Verma filed a Form 4 for a grant of 3,963 restricted stock units (RSUs) on 11/12/2025.
The RSUs were received for no consideration and vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028. Each RSU corresponds to one share of Cencora common stock, and the filing lists 3,963 derivative securities beneficially owned Direct (D) following the transaction.
Cencora (COR) Executive Vice President Elizabeth S. Campbell filed a Form 4 disclosing equity changes. On 11/13/2025, she acquired 20,613 shares of common stock at $0 upon performance share unit vesting, and a same‑day withholding transaction covered taxes for 9,532 shares at $312.53.
Separately, on 11/12/2025 she received a grant of 3,523 RSUs that vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028. Following these transactions, she beneficially owned 26,388.141 shares, held directly.
Cencora, Inc. (COR) reported insider equity activity by its SVP & Chief Accounting Officer, Lazarus Krikorian. On 11/13/2025, 2,434 shares of common stock were acquired at $0 upon meeting performance criteria, bringing direct holdings to 21,642 shares. The same day, 1,059 shares were disposed at $312.53 to satisfy tax withholding, resulting in 20,583 shares directly owned after the transactions.
In a separate equity grant, on 11/12/2025 the officer received 2,271 Restricted Stock Units at $0. These RSUs vest in three equal installments on 11/12/2026, 11/12/2027, and 11/12/2028.